Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Kinas nasjonale studie av binyrevenøs prøvetaking (CNAVS)

11. november 2026 oppdatert av: Xiongjing Jiang, Chinese Academy of Medical Sciences, Fuwai Hospital

En nasjonal multisenterstudie av adrenal venøs prøvetaking for subtypediagnose av primær aldosteronisme i Kina

This multicenter study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of adrenal venous sampling (AVS) via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be aslo analyzed in this study.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, and its most common subtypes are aldosterone-producing adenoma and idiopathic hyperaldosteronism, which account for 95% to 98% of PA. Subtype diagnosis is crucial for the treatment of primary aldosteronism, which conducts the appropriate treatment strategy. Currently, adrenal venous sampling (AVS) serves as the gold standard for subtyping of PA. How to improve the success rate of AVS has been a hot topic in the field of primary aldosteronism. This multicenter registry study intends to combine retrospective analysis and prospective registry to evaluate the success rate and safety of AVS via antecubital and femoral approach for patients with primary aldosteronism. The consistency of AVS with pathological results and clinical outcomes, the factors affecting the success of AVS, and the optimal population for AVS will be also analyzed in this study.

Studietype

Observasjonsmessig

Registrering (Antatt)

1500

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina, 100034
        • Peking University First Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wei Ma, MD
      • Beijing, Beijing Municipality, Kina, 100029
        • China-Japan Friendship Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wuqiang Che, MD
      • Beijing, Beijing Municipality, Kina, 100037
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Hovedetterforsker:
          • Hui Dong, MD
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiongjing Jiang, MD
      • Beijing, Beijing Municipality, Kina, 100022
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lin Pi, MD
      • Beijing, Beijing Municipality, Kina, 101100
        • Beijing Luhe Hospital, Capital Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dong Zhao, MD,PHD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Kina, 401147
        • Chongqing General Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rui He, MM
      • Chongqing, Chongqing Municipality, Kina, 400000
        • The First Affiliated Hospital of Chongqing Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dongying Zhang, MD
      • Chongqing, Chongqing Municipality, Kina, 404100
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xianhu Luo, MD
    • Fujian
      • Xiamen, Fujian, Kina, 361016
        • Cardiovascular Hospital Xiamen University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tao Ye, MD
    • Gansu
      • Lanzhou, Gansu, Kina, 730000
        • Lanzhou University Second Hospital
        • Ta kontakt med:
        • Ta kontakt med:
          • Heng Yu
        • Hovedetterforsker:
          • Wei Liang, MD
    • Guangdong
      • Foshan, Guangdong, Kina, 528211
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yayan Han, MD
      • Guangzhou, Guangdong, Kina, 510080
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Hovedetterforsker:
          • Yingqing Feng, MD
        • Ta kontakt med:
        • Ta kontakt med:
      • Shenzhen, Guangdong, Kina, 518112
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhenzhong Zheng, MD,PHD
      • Shenzhen, Guangdong, Kina, 518116
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tongqing Lu, MD
    • Guangxi
      • Nanning, Guangxi, Kina, 530000
        • The First Affiliated Hospital of Guangxi Medical University
        • Ta kontakt med:
        • Ta kontakt med:
          • Jianling LI
        • Hovedetterforsker:
          • Jiangnan Huang, MD
      • Nanning, Guangxi, Kina, 547000
        • Nanning Third People's Hospital
        • Ta kontakt med:
          • Yongqi Xiao, MS
          • Telefonnummer: 86-07713394390
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yongqi Xiao, MS
    • Guizhou
      • Kaili, Guizhou, Kina, 556000
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yumei Xiang, MD
    • Hebei
      • Tangshan, Hebei, Kina, 063000
        • Tangshan hongci Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Guijuan Zhang, MD
    • Heilongjiang
      • Harbin, Heilongjiang, Kina, 150001
        • The First Affiliated Hospital of Harbin Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dechao Zhao, MD
    • Henan
      • Zhengzhou, Henan, Kina, 450003
        • Henan Provincial People's Hospital
        • Hovedetterforsker:
          • Min Liu, MD
        • Ta kontakt med:
        • Ta kontakt med:
      • Zhengzhou, Henan, Kina, 450000
        • Fuwai Central China Cardiovascular Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Qiuping Zhao, PhD
      • Zhengzhou, Henan, Kina, 450007
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Shuhua Yu, MM
      • Zhengzhou, Henan, Kina, 450018
        • Zhengzhou Yihe Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Liang An, BD
      • Zhoukou, Henan, Kina, 466000
        • Zhoukou Central Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Baogong Wang, MD
    • Hubei
      • Wuhan, Hubei, Kina, 430060
        • Renmin Hospital of Wuhan University
        • Ta kontakt med:
        • Hovedetterforsker:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, Kina, 441021
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Ta kontakt med:
        • Ta kontakt med:
          • Luhong Li
        • Hovedetterforsker:
          • Qing'an Li
      • Yichang, Hubei, Kina, 443000
        • Yichang Central People's Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yunbo Lv, MD
    • Jiangxi
      • Nanchang, Jiangxi, Kina, 330006
        • Second Affiliated Hospital of Nanchang University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yifei Dong, MD,PhD
      • Nanchang, Jiangxi, Kina, 330038
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Ta kontakt med:
          • Haohang Ruan, MBBS
          • Telefonnummer: 86-0791-87721036
        • Ta kontakt med:
        • Hovedetterforsker:
          • Haohang Ruan, MBBS
    • Jilin
      • Changchun, Jilin, Kina, 130051
        • Jilin Province FAW General ospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wenhai Wang, MM
    • Liaoning
      • Dalian, Liaoning, Kina, 116011
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Yinong Jiang, MD
    • Ningxia
      • Yinchuan, Ningxia, Kina, 750000
        • The First People's Hospital of Yinchuan
        • Ta kontakt med:
        • Ta kontakt med:
          • Yunhai Ma
        • Hovedetterforsker:
          • Fang Chen, PD
    • Qinghai
      • Xining, Qinghai, Kina, 810000
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiaozhou Wang
    • Shaanxi
      • Xi'an, Shaanxi, Kina, 710018
        • Xi'an People's Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kang Cheng, MD&PhD
    • Shandong
      • Jinan, Shandong, Kina, 250012
      • Jinan, Shandong, Kina, 250013
        • Central Hospital Affiliated to Shandong First Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Rui Xu, MD &. PhD
      • Liaocheng, Shandong, Kina, 252200
        • People's Hospital of Donga County, Shandong Province
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Xiaoli Wang, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 200025
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jianzhong Xu, MD,PhD
      • Shanghai, Shanghai Municipality, Kina, 200062
        • Shanghai Putuo District Central Hospital
        • Ta kontakt med:
          • Junqing Gao
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zongjun Liu, MD
    • Shanxi
      • Taiyuan, Shanxi, Kina, 030001
        • The second hospital of Shanxi medical unversity
        • Hovedetterforsker:
          • Bin Yang, MD
        • Ta kontakt med:
        • Ta kontakt med:
    • Sichuan
      • Chengdu, Sichuan, Kina, 611130
        • Chengdu Fifth People's Hospital
        • Ta kontakt med:
          • Mingjian Lang, MD
          • Telefonnummer: 86-028-82710681
          • E-post: zcl628@163.com
        • Ta kontakt med:
          • Congliang Zhou
        • Hovedetterforsker:
          • Mingjian Lang, MD
      • Chengdu, Sichuan, Kina, 610500
        • The First Affiliated Hospital of Chengdu Medical College
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Peijian Wang, MD
      • Chengdu, Sichuan, Kina, 610031
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhen Zhang, MD
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, Kina, 300211
        • The Second Hospital of Tianjin Medical University
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Changle Liu, MD
      • Tianjin, Tianjin Municipality, Kina, 300052
        • Tianjin Medical University General Hospital,
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Dianxun Fu, MD
      • Tianjin, Tianjin Municipality, Kina, 300457
        • TEDA International Cardiovascular Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Weiqiang Chen, MM
    • Xinjiang
      • Yili Kazak Autonomous Prefecture, Xinjiang, Kina, 835000
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Wei Li, MB
    • Yunnan
      • Kunming, Yunnan, Kina, 650102
        • Fuwai Yunnan Cardiovascular Hospital
        • Ta kontakt med:
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zihong Guo, Bachelor
    • Zhejiang
      • Hangzhou, Zhejiang, Kina, 310000

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

N/A

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients with confirmed primary aldosteronism aged from 18 to 65 with no limits in sex

Beskrivelse

Inclusion Criteria:

  1. Aged from 18 to 65 with no limits in sex;
  2. Patients with confirmed primary aldosteronism;
  3. Patients or their legal representatives sign written informed consent approved by the ethics committee;

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: OTHER

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
The success rate of bilateral adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
The success rate of left adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Tidsramme: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Tidsramme: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Tidsramme: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Tidsramme: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Tidsramme: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Tidsramme: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Tidsramme: At AVS procedure

the cost of the procedure

At AVS procedure
pathological results(If the patient underwent adrenalectomy)
Tidsramme: 1 week After AVS procedure

Pathological types of primary aldosteronism(to compare the consistency between adrenal venous sampling results and histopathological results if the patients underwent adrenalectomy.)

1 week After AVS procedure

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Xiongjing Jiang, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

31. august 2028

Studiet fullført (Antatt)

31. august 2029

Datoer for studieregistrering

Først innsendt

21. desember 2023

Først innsendt som oppfylte QC-kriteriene

4. januar 2024

Først lagt ut (Faktiske)

5. januar 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

11. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere